B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...

There are different types of T-cell lymphoma, including: Cutaneous B-cell lymphoma (CBCL), also ... If the tumor cells look highly abnormal, it is high grade and more aggressive.

A new type of cell-based immunotherapy shows promise for B-cell lymphomas ... the CAR-NK cells to lymphoma cells. A total of 10 study participants experienced low-grade cytokine release syndrome ...

The committee reviewed data showing a 94 percent complete response rate as a third- or later-line treatment for refractory follicular lymphoma.

A new type of cell-based immunotherapy shows promise for B-cell lymphomas ... the CAR-NK cells to lymphoma cells. A total of 10 study participants experienced low-grade cytokine release syndrome ...

Patients with relapsed or refractory large B-cell lymphoma who received epcoritamab ... cell-associated neurotoxicity syndrome (ICANS) and grade 3 or greater cytokine release syndrome also ...

In Canada, 1 in 12 people live with a rare disease, and for most people affected, the cost of treatment is unaffordable. Canadians deserve a health care system that provides timely access to quality ...

Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving complete response Across clinical trials, Breyanzi has deliver ...